CLINICAL_TRIALS
trial_result
· 2025-03-10
Clinical Trial Update: Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent Medulloblastoma [EARLY_Phase 1]
Summary
An early-phase study examining intraventricular infusion of panobinostat (MTX110) into the fourth ventricle for recurrent medulloblastoma in children and adults…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Health Science Center, Houston | Conditions: Medulloblastoma | EARLY_Phase 1 | Status: COMPLETED